University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for (18)F-FDG-PET-guided dose escalation in oropharyngeal cancer: A planning study.

Teoh, M, Beveridge, S, Wood, K, Whitaker, S, Adams, E, Rickard, D, Jordan, T, Nisbet, Andrew and Clark, CH (2012) Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for (18)F-FDG-PET-guided dose escalation in oropharyngeal cancer: A planning study. Med Dosim.

[img]
Preview
Text
Teoh et al Med Dosim 2013.pdf - ["content_typename_Published version (Publisher's proof or final PDF)" not defined]
Available under License : See the attached licence file.

Download (1MB) | Preview
[img]
Preview
Text (licence)
SRI_deposit_agreement.pdf
Available under License : See the attached licence file.

Download (33kB) | Preview

Abstract

Fluorine-18-fluorodeoxyglucose-positron emission tomography ((18)F-FDG-PET)-guided focal dose escalation in oropharyngeal cancer may potentially improve local control. We evaluated the feasibility of this approach using volumetric-modulated arc therapy (RapidArc) and compared these plans with fixed-field intensity-modulated radiotherapy (IMRT) focal dose escalation plans. Materials and methods: An initial study of 20 patients compared RapidArc with fixed-field IMRT using standard dose prescriptions. From this cohort, 10 were included in a dose escalation planning study. Dose escalation was applied to (18)F-FDG-PET-positive regions in the primary tumor at dose levels of 5% (DL1), 10% (DL2), and 15% (DL3) above standard radical dose (65 Gy in 30 fractions). Fixed-field IMRT and double-arc RapidArc plans were generated for each dataset. Dose-volume histograms were used for plan evaluation and comparison. The Paddick conformity index (CI(Paddick)) and monitor units (MU) for each plan were recorded and compared. Both IMRT and RapidArc produced clinically acceptable plans and achieved planning objectives for target volumes. Dose conformity was significantly better in the RapidArc plans, with lower CI(Paddick) scores in both primary (PTV1) and elective (PTV2) planning target volumes (largest difference in PTV1 at DL3; 0.81 ± 0.03 [RapidArc] vs. 0.77 ± 0.07 [IMRT], p = 0.04). Maximum dose constraints for spinal cord and brainstem were not exceeded in both RapidArc and IMRT plans, but mean doses were higher with RapidArc (by 2.7 ± 1 Gy for spinal cord and 1.9 ± 1 Gy for brainstem). Contralateral parotid mean dose was lower with RapidArc, which was statistically significant at DL1 (29.0 vs. 29.9 Gy, p = 0.01) and DL2 (29.3 vs. 30.3 Gy, p = 0.03). MU were reduced by 39.8-49.2% with RapidArc (largest difference at DL3, 641 ± 94 vs. 1261 ± 118, p < 0.01). (18)F-FDG-PET-guided focal dose escalation in oropharyngeal cancer is feasible with RapidArc. Compared with conventional fixed-field IMRT, RapidArc can achieve better dose conformity, improve contralateral parotid sparing, and uses fewer MU.

Item Type: Article
Authors :
NameEmailORCID
Teoh, MUNSPECIFIEDUNSPECIFIED
Beveridge, SUNSPECIFIEDUNSPECIFIED
Wood, KUNSPECIFIEDUNSPECIFIED
Whitaker, SUNSPECIFIEDUNSPECIFIED
Adams, EUNSPECIFIEDUNSPECIFIED
Rickard, DUNSPECIFIEDUNSPECIFIED
Jordan, TUNSPECIFIEDUNSPECIFIED
Nisbet, AndrewA.Nisbet@surrey.ac.ukUNSPECIFIED
Clark, CHUNSPECIFIEDUNSPECIFIED
Date : 27 July 2012
Identification Number : 10.1016/j.meddos.2012.05.002
Depositing User : Symplectic Elements
Date Deposited : 06 Sep 2017 08:46
Last Modified : 31 Oct 2017 16:21
URI: http://epubs.surrey.ac.uk/id/eprint/804017

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800